DMP 📈 Dermapharm Holding SE - Overview

Dermapharm Holding SE is a German-based company that specializes in the manufacture and sale of off-patent branded pharmaceutical products, operating through a multi-segmented business model. This structure comprises three primary segments: Branded Pharmaceuticals and Other Healthcare Products, Parallel Import Business, and Herbal Extracts, allowing the company to diversify its offerings and cater to a wide range of healthcare needs. The company's product portfolio includes branded generics, over-the-counter (OTC) products, non-prescription healthcare products, and herbal extracts, in addition to parallel-imported originator pharmaceuticals, which are essentially branded drugs imported from other countries where they are approved for sale.

The company's product range extends to vitamins, minerals, and food supplements, further broadening its reach into the health and wellness sector. Dermapharm also focuses on specific therapeutic areas, including dermatology, allergology, pain and inflammation treatment, cardiovascular support, gynecology, and urology, offering targeted solutions for these conditions. Moreover, the company is involved in the cosmetics and medical devices markets, showcasing its commitment to comprehensive healthcare solutions. Under the axicorp brand, Dermapharm imports originator pharmaceuticals, which are then sold alongside its other products under various brand names such as Dekristol, Keltican, Tromcardin, Ketozolin, bite away, Herpotherm, and epiivo.

Founded in 1991 and headquartered in Grünwald, Germany, Dermapharm Holding SE operates as a subsidiary of Themis Beteiligungs-AG, positioning itself within a larger corporate structure. The company's financial and corporate information is available on its investor relations website, providing transparency and accessibility for investors and stakeholders. With its common stock listed under the ISIN DE000A2GS5D8 and classified under the GICS Sub Industry: Pharmaceuticals, Dermapharm Holding SE is clearly defined within the pharmaceutical sector, reflecting its core business activities and areas of expertise.